Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?
| العنوان: | Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept? |
|---|---|
| المؤلفون: | E Paietta |
| المصدر: | Bone Marrow Transplantation. 29:459-465 |
| بيانات النشر: | Springer Science and Business Media LLC, 2002. |
| سنة النشر: | 2002 |
| مصطلحات موضوعية: | Transplantation, medicine.medical_specialty, Leukemia, Neoplasm, Residual, business.industry, Cytodiagnosis, Induction chemotherapy, Hematology, Disease, Residual, medicine.disease, Minimal residual disease, Immunophenotyping, Surgery, Molecular Diagnostic Techniques, Monitoring, Immunologic, medicine, Humans, business, Intensive care medicine |
| الوصف: | The term minimal residual disease (MRD) in its currently accepted application refers to low-level disease detected in a whole variety of clinical situations. It is used to describe residual disease after suboptimal induction chemotherapy, but at the same time refers to the lowest levels of disease potentially compatible with cure or to molecularly defined relapse after long-term remission. This discussion intends to redefine MRD into some biologically relevant subcategories which may warrant their own independent terminology. |
| تدمد: | 1476-5365 0268-3369 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d1910f32d8e219bcc038694a6e84018 https://doi.org/10.1038/sj.bmt.1703388 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....0d1910f32d8e219bcc038694a6e84018 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14765365 02683369 |
|---|